RADIOISOTOPES

Online ISSN: 1884-4111 Print ISSN: 0033-8303
RADIOISOTOPESは日本アイソトープ協会が発行する学術論文誌です
Radioisotopes 72(1): 49-100 (2023)
doi:10.3769/radioisotopes.72.49

資料Materials (Data)

第9回全国核医学診療実態調査報告書The Present State of Nuclear Medicine Practice in Japan —A Report of the 9th Nationwide Survey in 2022—

（公社）日本アイソトープ協会医学・薬学部会　全国核医学診療実態調査専門委員会Subcommittee on Survey of Nuclear Medicine Practice in Japan, Medical Science and Pharmaceutical Committee, Japan Radioisotope Association
発行日：2023年3月15日Published: March 15, 2023
HTMLPDFEPUB3

日本アイソトープ協会では1982年から5年ごとに専門委員会を設けて全国核医学診療実態調査を行っており，第9回調査を2022年6月に行った。回答回収率は90％超であった。年間推定検査件数は単光子放出核種を用いた核医学検査が前回より2.7％増加した一方で，PET検査は約1.5％減少した。この結果，核医学検査総数は1.0％増加した。非密封RIを用いた核医学治療は131I-MIBGによる褐色細胞腫・パラガングリオーマや177Lu-ルテチウムオキソドトレオチドによる神経内分泌腫瘍の治療が新規に開始されたが，223Raと131Iを用いた治療件数の減少や一部薬剤の供給停止もあり，全体で17.7％減少した。核医学検査の総数はあまり変わらないが，核医学治療が大きく変化していることが示された。

The Subcommittee of Japan Radioisotope Association on Survey of Nuclear Medicine Practice in Japan has performed a nationwide questionnaire survey every five years since 1982. The latest questionnaire survey was performed in June 2022, resulting in more than 90％ response. The estimated total number of examinations using single photon emitters increased by 2.7％, whereas the number of PET examinations decreased by 1.5％ as compared to the survey in 2017. As a result, the total nuclear examinations increased by 1.0％. Unsealed radionuclide therapy was newly initiated for treatment of pheochromocytoma/paraganglioma with 131I-MIBG and neuroendocrine tumors with 177Lu-oxodotreotide, while treatments with 223Ra and 131I decreased and some products were discontinued. Therefore, the total number of unsealed radionuclide therapy decreased by 17.7％. The total number of nuclear medicine examinations did not change much, but unsealed radionuclide therapy showed significant changes.

Key words: single photon emitter; radionuclide therapy; single photon emission computed tomography (SPECT); positron emission tomography (PET); scintigraphy; radiopharmaceutical; nuclear medicine practice in Japan

© Japan Radioisotope Association 2023. This is an open access article distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License (https://creativecommons.org/licenses/by/4.0/)© Japan Radioisotope Association 2023. This is an open access article distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License (https://creativecommons.org/licenses/by/4.0/)

This page was created on 2023-01-31T13:30:22.278+09:00
This page was last modified on 2023-03-08T15:52:14.000+09:00

このサイトは（株）国際文献社によって運用されています。